Arteris (AIP) COO tax-related sale of 7,154 shares under 10b5-1 plan

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Arteris, Inc. Chief Operating Officer Laurent R. Moll reported multiple open-market sales of common stock primarily to cover taxes from the release of restricted stock units. He sold a total of 7,154 shares at prices between $17.65 and $18.23 per share and now directly holds 280,972 shares. According to the disclosure, these sales were required under the company’s equity plans as “sell to cover” transactions and were executed pursuant to a Rule 10b5-1 trading plan adopted on March 12, 2025, indicating they were not discretionary trades.

Insider Trade Summary 10b5-1

Net Seller: 7,154 shares ($127,184)

Net Sell 5 txns

Insider Moll Laurent R

Role Chief Operating Officer

Sold 7,154 shs ($127K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,552	$18.23	$28K
Sale	Common Stock	888	$17.6528	$16K
Sale	Common Stock	1,931	$17.6528	$34K
Sale	Common Stock	1,890	$17.6528	$33K
Sale	Common Stock	893	$17.6528	$16K

Holdings After Transaction: Common Stock — 280,972 shares (Direct)

Footnotes (1)

Shares sold to satisfy the Reporting Person's tax liability arising as a result of the release of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 12, 2025.

Key Figures

Shares sold: 7,154 shares Highest sale price: $18.23 per share Other sale price: $17.6528 per share +4 more

7 metrics

Shares sold 7,154 shares Total common stock sold across reported transactions

Highest sale price $18.23 per share Open-market sale on April 6, 2026

Other sale price $17.6528 per share Multiple open-market sales on April 2, 2026

Shares held after transactions 280,972 shares Direct ownership following latest reported sale

Number of sale transactions 5 transactions Non-derivative open-market sales of common stock

Net share direction -7,154 shares Net-sell activity from this Form 4

10b5-1 plan adoption date March 12, 2025 Date trading plan referenced for these transactions

Key Terms

restricted stock units, sell to cover, tax withholding obligations, Rule 10b5-1 trading plan, +1 more

5 terms

restricted stock units financial

"tax liability arising as a result of the release of restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

sell to cover financial

"require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction"

Sell to cover is when a person who receives company stock through options or awards sells just enough shares immediately to pay required taxes, exercise costs, or fees, keeping the rest. Think of it like cashing part of a bonus to cover the tax bill so you can keep the remainder. For investors, it can create predictable small selling pressure and slightly change the number of shares actually held by insiders without increasing long‑term dilution.

tax withholding obligations financial

"require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction"

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan that was adopted"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Form 4 Insider Transactions: What Each Field Means →

04/06/2026 - 06:00 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Moll Laurent R

(Last)

(First)

(Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL

CALIFORNIA

95008

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Operating Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	04/02/2026		S⁽¹⁾		888	D	$17.6528	287,238	D
Common Stock	04/02/2026		S⁽¹⁾		1,931	D	$17.6528	285,307	D
Common Stock	04/02/2026		S⁽¹⁾		1,890	D	$17.6528	283,417	D
Common Stock	04/02/2026		S⁽¹⁾		893	D	$17.6528	282,524	D
Common Stock	04/06/2026		S⁽²⁾		1,552	D	$18.23	280,972	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Shares sold to satisfy the Reporting Person's tax liability arising as a result of the release of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

2. Transaction made pursuant to a 10b5-1 trading plan that was adopted by the Reporting Person on March 12, 2025.

Remarks:

	/s/ Paul Alpern, as Attorney-in-Fact for Moll Laurent R	04/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Arteris (AIP) report for Laurent R. Moll?

Arteris reported that Chief Operating Officer Laurent R. Moll sold 7,154 shares of common stock. The shares were sold in several open-market transactions at prices between $17.65 and $18.23 per share, primarily to cover tax obligations from restricted stock units.

Why did Arteris (AIP) COO Laurent R. Moll sell 7,154 shares?

The filing states the shares were sold to satisfy Laurent R. Moll’s tax liability from the release of restricted stock units. Under Arteris’ equity incentive plans, these “sell to cover” transactions fund tax withholding obligations rather than reflecting discretionary portfolio decisions.

At what prices did Laurent R. Moll’s recent Arteris (AIP) stock sales occur?

Laurent R. Moll’s reported sales of Arteris common stock occurred at prices between $17.6528 and $18.23 per share. These trades were executed in the open market and are described as part of a mandated sell-to-cover process for tax withholding obligations.

How many Arteris (AIP) shares does Laurent R. Moll hold after the reported sales?

After the reported transactions, Laurent R. Moll directly holds 280,972 shares of Arteris common stock. This remaining position, disclosed in the Form 4, shows he retained a substantial stake following the 7,154 shares sold for tax-related reasons.

Were Laurent R. Moll’s Arteris (AIP) stock sales under a Rule 10b5-1 plan?

Yes. The footnotes explain that the transactions were executed under a Rule 10b5-1 trading plan adopted on March 12, 2025. Such pre-arranged plans schedule trades in advance, indicating the timing of these sales was not based on subsequent market developments.

Do Laurent R. Moll’s Arteris (AIP) stock sales represent discretionary selling?

The filing states these sales do not represent discretionary trades. They were mandated by Arteris’ equity incentive plans as sell-to-cover transactions to fund tax withholding on restricted stock unit releases, and were carried out under a pre-established Rule 10b5-1 trading plan.